Amdocs (DOX) to Release Quarterly Earnings on Tuesday

Amdocs (NASDAQ:DOXGet Free Report) will likely be releasing its Q1 2026 results after the market closes on Tuesday, February 3rd. Analysts expect Amdocs to post earnings of $1.75 per share and revenue of $1.1534 billion for the quarter. Parties may review the information on the company’s upcoming Q1 2026 earning report for the latest details on the call scheduled for Tuesday, February 3, 2026 at 5:00 PM ET.

Amdocs Stock Performance

Shares of DOX stock opened at $81.94 on Friday. The company has a market capitalization of $8.85 billion, a price-to-earnings ratio of 16.23, a price-to-earnings-growth ratio of 1.37 and a beta of 0.40. The company has a debt-to-equity ratio of 0.23, a quick ratio of 1.17 and a current ratio of 1.17. Amdocs has a one year low of $74.32 and a one year high of $95.41. The company’s 50-day moving average is $80.31 and its 200 day moving average is $82.85.

Amdocs Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, January 30th. Stockholders of record on Wednesday, December 31st were issued a dividend of $0.527 per share. This represents a $2.11 dividend on an annualized basis and a dividend yield of 2.6%. The ex-dividend date of this dividend was Wednesday, December 31st. Amdocs’s dividend payout ratio (DPR) is presently 41.78%.

Analyst Upgrades and Downgrades

DOX has been the topic of several research analyst reports. Stifel Nicolaus lowered their price target on Amdocs from $100.00 to $97.00 and set a “buy” rating on the stock in a report on Wednesday, November 12th. Wolfe Research reissued a “peer perform” rating on shares of Amdocs in a research report on Thursday, November 13th. Wall Street Zen lowered shares of Amdocs from a “buy” rating to a “hold” rating in a research report on Saturday, January 3rd. Bank of America dropped their price objective on shares of Amdocs from $100.00 to $97.00 and set a “buy” rating on the stock in a report on Wednesday, November 12th. Finally, Weiss Ratings reiterated a “hold (c)” rating on shares of Amdocs in a research report on Tuesday. Two equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. According to data from MarketBeat, Amdocs presently has an average rating of “Moderate Buy” and a consensus target price of $97.00.

Check Out Our Latest Stock Analysis on DOX

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently made changes to their positions in DOX. CIBC Private Wealth Group LLC raised its stake in Amdocs by 190.2% during the third quarter. CIBC Private Wealth Group LLC now owns 595 shares of the technology company’s stock valued at $49,000 after purchasing an additional 390 shares in the last quarter. CIBC Bancorp USA Inc. bought a new stake in shares of Amdocs in the 3rd quarter worth about $502,000. Caitong International Asset Management Co. Ltd raised its position in shares of Amdocs by 68.4% during the 3rd quarter. Caitong International Asset Management Co. Ltd now owns 795 shares of the technology company’s stock valued at $65,000 after buying an additional 323 shares in the last quarter. Advisory Services Network LLC purchased a new position in Amdocs in the third quarter worth about $42,000. Finally, CANADA LIFE ASSURANCE Co increased its stake in Amdocs by 4.5% during the third quarter. CANADA LIFE ASSURANCE Co now owns 48,386 shares of the technology company’s stock worth $3,939,000 after acquiring an additional 2,087 shares during the last quarter. Institutional investors own 92.02% of the company’s stock.

About Amdocs

(Get Free Report)

Amdocs (NASDAQ: DOX) is a global software and services provider specializing in solutions for communications, media and entertainment companies. The company designs, develops and integrates revenue management, customer experience and digital services platforms that enable service providers to launch and monetize new offerings, streamline operations and enhance subscriber engagement. Amdocs’ product suite encompasses billing and order management, customer relationship management, digital commerce and network function virtualization, supported by professional services for implementation, integration and managed operations.

Founded in 1982 and structured as a separate public company in 1998, Amdocs has its corporate headquarters in Chesterfield, Missouri, and maintains major development centers in Ra’anana, Israel.

Read More

Earnings History for Amdocs (NASDAQ:DOX)

Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.